Lavipharm

About Lavipharm

Established in 1911, Lavipharm is an EU-based company engaged in the development, manufacturing & distribution of Rx & OTC products, with a solid commercial footprint in Greece, focusing on Cardiometabolic, Oncology & Pain, CNS, General Medicine & Medical Cannabis. Lavipharm is an experienced transdermal systems manufacturer, supplying to most European countries, Canada, S. Korea, Taiwan, LATAM, MENA & other markets. Lavipharm also offers CDMO services for transdermals, liquids & semi-solids.

  • Country/Region:
    Greece
  • On CPHI since:
    2019
  • Certificates:
    1
  • Employees:
    250 - 499
Company types
Distributor/Import Export
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Finished Formulation products Distributor/Buyer
OTC
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from Lavipharm (2)

  • Nitrong, Trinipatch, Nitrosylon, Triniplas, Keritrina

    Product Nitrong, Trinipatch, Nitrosylon, Triniplas, Keritrina

    A latest generation nitroglycerin patch for the treatment of coronary artery disease and heart failure. Transdermal Drug Delivery Systems (TDDS) are one of the pharmaceutical technologies, in which Lavipharm is actively and successfully engaged. TDDSs are placed on the skin and allow specific drug subs...
  • Fentadur, Dolfen, Durfenta, Opiodur, Fentapon, Lafene

    Product Fentadur, Dolfen, Durfenta, Opiodur, Fentapon, Lafene

    A fentanyl transdermal delivery system, developed by Lavipharm's research laboratories in the USA  is a small, thin and easy to adhere patch for the management of chronic pain. It is designed to deliver the analgesic substance fentanyl safely and effectively through the skin. This three-day pa...